REGISTERED
on 01 Oct 2024
Last Applicant/ Owned by
Ugland House
Grand Cayman
KY
KY1-1104
Serial Number
98069926 filed on 03rd Jul 2023
Registration Number
7525176 registered on 01st Oct 2024
Correspondent Address
Eric Lamb
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
XDC THE BIOCONJUGATION LEADER
Development of products for others in the field of pharmaceuticals; pharmaceutical drug development services; research and development of new products in the field of pharmaceuticals; biochemical research and development; custom design and development of chemical reagent antibodies and conjugate antibodies; research and development in the pharmaceutical, biomedicine and biotechnology fields; resea Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Development of products for others in the field of pharmaceuticals; pharmaceutical drug development services; research and development of new products in the field of pharmaceuticals; biochemical research and development; custom design and development of chemical reagent antibodies and conjugate antibodies; research and development in the pharmaceutical, biomedicine and biotechnology fields; research and development of antibodies; research and development of conjugated antibodies; biomedical research services; development of pharmaceutical preparations and medicines; research and development of antibody-drug conjugates; research and development of drug conjugates; preclinical research and evaluation of new drugs; consulting services in the field of technology development; research and development of new products for others; scientific research and development
First Use Date in General
20th Oct 2023
First Use Date in Commerce
20th Oct 2023
Class [040]
Treatment & Processing of Materials Services
Custom assembling of materials for others; custom manufacturing of pharmaceuticals; custom manufacturing of drug conjugates; custom production of pharmaceuticals; custom production of biological preparations; custom manufacturing of antibody-drug conjugates; custom manufacturing of chemical reagents; custom manufacturing of pharmaceutical preparations; custom manufacturing of biomedical preparations; custom manufacture of drug conjugates; processing of pharmaceutical preparations; processing or treating of chemical reagents; processing of antibody drugs; custom manufacturing of antibody drugs; processing of biomedical preparations; processing of biotechnology drug
First Use Date in General
20th Oct 2023
First Use Date in Commerce
20th Oct 2023
Mark Details
Serial Number
No 98069926
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.03.03 -
Incomplete ovals
26.03.13 -
Two ovals
26.03.16 -
Ovals touching or intersecting
Legal History
| Status Date | Action Taken |
|---|---|
| 01st Oct 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 01st Oct 2024 | REGISTERED-PRINCIPAL REGISTER |
| 28th Aug 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 28th Aug 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 07th Jul 2024 | STATEMENT OF USE PROCESSING COMPLETE |
| 06th Jul 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 29th May 2024 | TEAS STATEMENT OF USE RECEIVED |
| 29th May 2024 | USE AMENDMENT FILED |
| 06th Feb 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 12th Dec 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |